期刊文献+

溪黄草对代谢综合征患者血栓前状态及前炎性状态标志物的作用 被引量:2

Effect of Isodon.serra(Maxim) Kudo against the Markers of Prekronbotic state and Preimflammation state in Metabolize syndrome
下载PDF
导出
摘要 【目的】探讨溪黄草对代谢综合征患者血栓前状态及前炎性状态标志物的作用。【方法】选择代谢综合征血栓前状态及前炎性状态标志物异常患者100例,按区组随机法分成2组,每组50例,健康对照组50例。Ⅰ组和Ⅱ组每次均用溪黄草5g加凉开水60mL,保持50~60℃浸泡1h后饮服,连服28d,Ⅰ组每日服1次;Ⅱ组每日服2次,上下午各1次。Ⅰ组和Ⅱ组分别于治疗前1d、治疗后29d查ET、VwF、GMP-140、DD、hs-CRP和肝肾功能,治疗后第7、14、21天查肝肾功能。对照组于入选时查ET、VwF、GMP-140、DD、hs-CRP。2个治疗组治疗前分别与空白对照组比较,2个治疗组治疗前后分别比较、组间分别比较。【结果】①治疗组Ⅰ和治疗组Ⅱ治疗前的ET、VwF、GMP-140、DD及hs-CRP分别与空白对照组对比,差异有显著性(P均﹤0.01)。②治疗组Ⅰ和治疗组Ⅱ治疗前后的ET、VwF、GMP-140、DD及hs-CRP对比,差异有统计学意义(P均﹤0.05)。③治疗组Ⅰ与治疗组Ⅱ治疗后组间的ET、VwF、GMP-140、DD及hs-CRP对比,有差异但无有统计学意义(P均﹥0.05)。【结论】溪黄草可改善代谢综合征患者血栓前状态及前炎性状态。 [Objective] To evaluate the effect of Isodon.serra (Maxim)Kudo against the markers of Prekronbotic state and Preimflammation state in Metabolize syndrome. [ Methods] 100 patients with the abnormal markers of Prekronbotic state and Preimflammation state in Metabolize syndrome were randomized to treatment group Ⅰ (Group Ⅰ , n=50) and treatment group Ⅱ (Group Ⅱ, n = 50). they &inked with Isodon.serra(Maxim) Kudo 5 g with 50-60 degrees 50 mL water soaking water after 60 minutes for 28 days (Group Ⅰ q.d,Groups Ⅱ b.i.d). Healthy controls (Groups Ⅲ,n = 50) without treatment,another. The groupsⅠ and Ⅱ were detected plasma ET,VwF,GMP-140,DD,hs-CRP,ALT,AST and BNU in the day before treatment and 29^st day after treatment,also were detected plasma ALT, AST and BUN in 7^st, 14^st, and 21^st day after treatment, respecitely. [Results] ①It has remarkable difference that the all levels of plasma ET,VwF,GMP-140,DD and hs-CRP before treatment in groups Ⅰ and Ⅱ compared with its in Groups Ⅲ (P 〈 0.01 ), respecitively. ②It has remarkable difference that the all levels of plasma ET, VwF, GMP-140,DD and hs-CRP before treatment compared with its after treatment(P 〈 0.05) in groups Ⅰ and Ⅱ ,respecitely. ③There were no remarkable difference for the all levels of plasma ET,VwF,GMP-140,DD and hs-CRP after treatment between groups Ⅰ and Ⅱ (P 〉 0.05), respecitively. [Conclusion] Isodon.serra (Maxim) Kudo can improve the markers of prekronbotic state and preimflammation state in metabolize syndrome.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2009年第A03期196-198,201,共4页 Journal of Sun Yat-Sen University:Medical Sciences
关键词 溪黄草 代谢综合征 血栓前状态 前炎性状态 标志物 Isodon.serra(Maxim)Kudo metabolize syndrome prethrombotie state preimflammation state markers
  • 相关文献

参考文献6

二级参考文献36

  • 1李广义 宋万志 季庆义 等.溪黄草二萜成分的研究[J].中药通报,1984,9(5):29-30.
  • 2Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation,2002,105 (9) : 1135-1143.
  • 3Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol, 1998,31 (7) : 1460-1465.
  • 4Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial. Circulation, 2000, 102 (18) :2165-2168.
  • 5Ridker PM. High-sensitivity C-reactive protein:potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation,2001,103(13) :1813-1818.
  • 6Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood, 1993,82(2) :513-520.
  • 7Pasceri V,Cheng JS,Willerson JT,et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation, 2001,103(21) :2531-2534.
  • 8Abbasi F, Brown BW Jr, Lamendola C, et al. Relationship between obesity, insulin resistance, and coronary heart disease rise J Am Coll Cardiol,2002,40(5) :937-943.
  • 9Grundy SM, Brewer HB Jr, Cleeman JI, et aL Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 2004,109 ( 3 ) : 433-438.
  • 10Kuller LH, Tracy RP, Shaten J, et al. Relation of C-reactive protein and coronary heart disease in the MRFTT nested casecontrol study. Am J Epidemiol, 1996,144(6) :537-547.

共引文献29

同被引文献66

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部